Published in Indian J Med Res on February 01, 1981
Protection against West Nile virus induced by a previous injection with dengue virus. Am J Epidemiol (1971) 1.42
Histological studies of the monkey neurovirulence of group B arboviruses. I. A semiquantitative grading scale. Am J Epidemiol (1965) 1.24
Recovery from primary infection with Langat E5 virus in normal and cyclophosphamide treated mice: relative roles of virus multiplication, interferon, antibody and serum protective factor. Am J Epidemiol (1969) 1.14
The effect of cyclophosphamide treatment on experimental arbovirus infections. Am J Epidemiol (1969) 1.11
Gastrointestinal cancer mortality in New Jersey counties, and the relationship with environmental variables. Int J Epidemiol (1983) 1.09
Role of serum protective factor (SPF) in Langat virus infection of neonatally thymectomized, cyclophosphamide-treated, or antilymphocyte-treated mice. J Immunol (1969) 1.05
Acute myocardial infarction in Newark, N.J. A study of racial incidence. Arch Intern Med (1977) 1.05
Cross-protection with group B arboviruses in mice treated with cyclophosphamide: role of serum antibody, viremia, and virus multiplication in the brain. Am J Epidemiol (1969) 1.04
Histological studies of the monkey neurovirulence of group B arboviruses. II. Selection of indicator centers. Am J Epidemiol (1966) 1.02
A chick embryo attenuated strain (TP21 E5) of Langat virus. I. Virulence of the virus for mice and monkeys. Am J Epidemiol (1966) 1.00
Histological studies of the monkey neurovirulence of group B arboviruses. IV. Evaluation of an attenuated strain (E5) of Langat virus. Am J Epidemiol (1968) 0.98
Vaccination of human volunteers against Russian spring-summer (RSS) virus complex with attenuated Langat E5 virus. Bull World Health Organ (1970) 0.95
Carcinoma of the cervix in Newark, New Jersey, 1970-76. A very low in situ: invasive ratio. J Reprod Med (1981) 0.93
Histological studies of the monkey neurovirulence of group B arboviruses. 3. Relative virulence of selected viruses. Am J Epidemiol (1967) 0.92
A protective mechanism induced by live group B arboviruses against heterologous group B arboviruses independent of serum neutralizing antibodies or interferon. Am J Epidemiol (1967) 0.91
Life time occupation, smoking, caffeine, saccharine, hair dyes and bladder carcinogenesis. Int J Epidemiol (1982) 0.90
The mechanism of cross-protection afforded by dengue virus against West Nile virus in hamsters. J Hyg (Lond) (1972) 0.89
A chick embryo attenuated strain (TP21 E5) of Langat virus. II. Stability after passage in various laboratory animals and tissue cultures. Am J Epidemiol (1966) 0.89
A chick embryo attenuated strain (TP21 E5) of Langat virus. 3. The ability to protect against homologous virus and Powassan virus in cross-challenge experiments. Am J Epidemiol (1966) 0.88
Maternal and cord blood metal concentrations and low birth weight--a case-control study. Am J Clin Nutr (1978) 0.87
Plasma concentrations of calcium, chromium, copper, iron, magnesium, and zinc in maternal and cord blood and their relationship to low birth weight. J Lab Clin Med (1978) 0.86
Composition of tobaccos from countries with high and low incidences of lung cancer. I. Selenium, polonium-210, Alternaria, tar, and nicotine. J Natl Cancer Inst (1981) 0.84
Role of serum protective factor and neutralizing antibody in pathogenesis of experimental infection with Langat virus in mice. J Infect Dis (1970) 0.84
Immunization of mice against Russian spring-summer virus complex and monkeys against Powassan virus with attenuated Langat E5 virus. Duration of protection. Am J Trop Med Hyg (1973) 0.84
Vitamin levels in low-birth-weight newborn infants and their mothers. Am J Obstet Gynecol (1977) 0.83
Cancer among blacks in Newark, New Jersey, 1970-1976: a national and international comparison. Cancer (1982) 0.82
Lead content of tissues of baby rats born of, and nourished by lead-poisoned mothers. J Lab Clin Med (1976) 0.80
A new specific humoral viral resistance factor, serum protective factor--some biologic and physical properties. J Immunol (1971) 0.79
Potentiation of the neurovirulence of langat virus infection by lead intoxication in mice. Exp Mol Pathol (1978) 0.79
Diet and cancer--an international study. Int J Epidemiol (1986) 0.78
Vitamin profiles in elderly persons living at home or in nursing homes, versus profile in healthy young subjects. J Am Geriatr Soc (1979) 0.78
The attenuation of the 26th mouse brain passage of New Guinea C strain of dengue 2 virus for use in the sequential immunization procedure against group B arboviruses. Am J Trop Med Hyg (1973) 0.77
Control of hepatitis B infection. The role of surveillance and an isolation hemodialysis center. JAMA (1981) 0.76
Intake of magnesium and toxicity of lead: an experimental model. Arch Environ Health (1979) 0.76
Potentiation of langat virus infection by lead intoxication--influence on host defenses. Acta Virol (1977) 0.76
Infant mortality in Newark, New Jersey. A study of sociodemographic and medical factors. Public Health Rep (1979) 0.75
Signification of high density and total cholesterol and triglycerides in acute myocardial infarction -- a case-control study. Clin Biochem (1981) 0.75
Emetine-induced cardiomyopathy in rabbits. J Submicrosc Cytol (1983) 0.75
Comparative evaluation of two lots of Wister RA 27/3 rubella virus vaccine in young children. J Hyg Epidemiol Microbiol Immunol (1980) 0.75
Cancer incidence and mortality in Newark, N. J. 1970-1974: a national comparison. Cancer (1981) 0.75
Live and inactivated vaccines of group B arboviruses: role of neutralizing antibody and serum protective factor. Nature (1969) 0.75
Primary and secondary prevention among adults: an analysis with comments on screening and health education. Prev Med (1976) 0.75
Serum protective factor: an antiviral humoral substance produced in vivo--identification and mechanism of action. Ann N Y Acad Sci (1977) 0.75
Passive transfer of acquired resistance in mice to group B Arboviruses by serum protective factor(s) (SPF) independent of serum neutralizing antibody or interferon. Am J Epidemiol (1968) 0.75
Central tumor registry--an overview. J Med Soc N J (1975) 0.75
Melanoma of the skin in New Jersey. J Med Soc N J (1978) 0.75
Epidemiologic and histologic patterns of Hodgkin's disease in blacks. Cancer (1977) 0.75
Geographic variations in coronary heart disease. A perspective on risk factors and prevention. Adv Myocardiol (1980) 0.75
Epidemiology of schizophrenia. Public Health Rev (1982) 0.75
Trends in cancer mortality in New Jersey--comparison of geographic distribution in 1950-1969 and 1969-1975. J Med Soc N J (1981) 0.75
Automobile accidents--seat belts and air bags. N J Med (1986) 0.75
Evaluation of hospital and commercial toxic screens. J Med Soc N J (1983) 0.75